Extracellular Vesicles and Circulating Nucleic Acids receives its first CiteScore of 4.1

On June 5, 2024, Elsevier officially released the 2023 CiteScore™ metrics, and we are pleased to announce that Extracellular Vesicles and Circulating Nucleic Acids (EVCNA) received its first CiteScore of 4.1 for 2023, positioning it at 33 among 103 titles (Q2) in the “Biochemistry, Genetics and Molecular Biology (miscellaneous)” category and at 92 among 221 titles (Q2) in the “General Biochemistry, Genetics and Molecular Biology” category.

CiteScore™, developed by Elsevier, is a comprehensive, transparent, and current metric designed to gauge the citation impact of scholarly journals. It provides a robust assessment of journal performance, considering all content published in a journal, not just research articles, and offers a broader perspective on journal quality compared to traditional impact metrics.

The achievement of the first CiteScore of 4.1 reflects the substantial citation impact and influence of research articles published in EVCNA. This recognition not only acknowledges the excellence of the scientific contributions but also highlights their growing significance in advancing biomedical research and clinical applications.

EVCNA extends sincere gratitude to our esteemed Editorial Board members, Guest Editors, authors, reviewers, and readers for their invaluable contributions to the success. Their dedication, expertise, and commitment to advancing scientific knowledge have been instrumental in achieving this significant milestone. EVCNA will continue to push the boundaries of scientific discovery, foster interdisciplinary collaboration, and contribute to transformative advancements in biomedicine.

Editor: Tina Yu
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully submitted by the Editorial Office of Extracellular Vesicles and Circulating Nucleic Acids